Otwarty dostęp

Predictors and Consequences of Subclinical Renal Impairment in Patients with Vascular Disease

, , ,  oraz   
26 gru 2024

Zacytuj
Pobierz okładkę

FIGURE 1.

Significant differences in cystatin C levels according to the presence or absence of diabetes mellitus and diuretic therapy (A) and in NGAL levels according to the presence or absence of diuretic therapy (B). Data expressed as means ± s.d.; p values obtained using the unpaired t-test.
Significant differences in cystatin C levels according to the presence or absence of diabetes mellitus and diuretic therapy (A) and in NGAL levels according to the presence or absence of diuretic therapy (B). Data expressed as means ± s.d.; p values obtained using the unpaired t-test.

Correlation analysis of patient characteristics and cystatin C levels

Parameter Correlation coefficient p value
Age 0.38 (0.16–0.57) <0.001*
Body mass index 0.52
Heart failure (NYHA class) 0.34
Hemoglobin −0.30 (−0.50 to −0.07) 0.01*
White blood cells 0.47
Platelets 0.52
Glucose 0.32 (0.10–0.52) <0.01*
Total cholesterol 0.52
LDL-cholesterol 0.68
HDL-cholesterol −0.54 (−0.74 to −0.31) <0.01*
Triglycerides 0.12
Total protein 0.72
Albumin −0.67 (−0.88 to −0.42) 0.02*
Uric acid 0.70 (0.50–0.87) <0.0001*
Potassium 0.65 (0.43–0.82) 0.0001*

Correlation analysis of patient characteristics and NGAL levels

Parameter Correlation coefficient p value
Age 0.31
Body mass index 0.13
Heart failure (NYHA class) 0.26 (0.03–0.46) 0.02*
Hemoglobin 0.94
White blood cells 0.68 (0.45–0.88) 0.01*
Platelets 0.41
Glucose 0.51
Total cholesterol 0.89
LDL-cholesterol 0.47
HDL-cholesterol −0.60 (−0.82 to −0.44) 0.03*
Triglycerides 0.76
Total protein 0.96
Albumin −0.52 (−0.72 to −0.29) <0.01*
Uric acid 0.78 (0.55–0.97) 0.001*
Potassium 0.40 (0.18–0.58) <0.001*

Multiple linear regression analysis of factors associated with increased cystatin C levels

Parameter Correlation coefficient Standard error p value
Age 0.40 0.01 0.30
Hemoglobin −0.30 0.02 0.46
Glucose 0.32 0.01 0.73
HDL-cholesterol −0.20 0.01 0.03*
Albumin −0.24 0.02 0.04*
Uric acid 0.56 0.02 <0.001*
Potassium 0.61 0.07 0.0001*
Diuretic therapy 0.42 0.03 0.02*

Main characteristics of the study participants (n = 71)

Parameter Value
Age (years) 63.8 ± 9.3
Male sex (n, %) 47 (66.1%)
Body mass index, mean (kg/m2) 28.6 ± 3.9
Medical history
  Arterial hypertension (n, %) 65 (91.5%)
  Diabetes mellitus (n, %) 30 (42.2%)
  Heart failure (NYHA class) 2 (2-2)
Ongoing therapy
  ACEI (n, %) 49 (69.0%)
  ARB (n, %) 15 (21.1%)
  Diuretic (n, %) 30 (42.2%)
  Statin (n, %) 70 (98.5%)
Laboratory parameters
  White blood cells (/mm3) 7,648 ± 1,876
  Platelets (/mm3) 231,812 ± 66,047
  Hemoglobin (g/dl) 13.4 ± 1.5
  Glucose (mg/dl) 141.1 ± 62.7
  Total cholesterol (mg/dl) 163.6 ± 47.8
  LDL-cholesterol (mg/dl) 90.9 ± 41.6
  HDL-cholesterol (mg/dl) 40.6 ± 24.3
  Triglycerides (mg/dl) 163.4 ± 104.5
  Total protein (g/dl) 66.0 ± 4.8
  Albumin (g/dl) 4.3 ± 0.3
  Uric acid (mg/dl) 6.2 ± 1.7
  Potassium (mEq/l) 3.9 ± 0.4
  Serum creatinine (mg/dl) 1.04 ± 0.32
  eGFR (ml/min/1.73 m2) 76.0 ± 23.0
  Cystatin C (mg/l) 1.10 ± 0.37
  NGAL (ng/ml) 75.8 ± 26.6

Multiple linear regression analysis of factors associated with increased NGAL levels

Parameter Correlation coefficient Standard error p value
Age 0.29 5.52 0.06
Hemoglobin 0.49 0.01 <0.01*
Glucose −0.46 0.04 0.03*
HDL-cholesterol −0.34 0.05 0.02*
Albumin 0.39 0.07 <0.01*
Uric acid 0.43 6.22 0.10
Potassium 0.28 5.80 0.31
Diuretic therapy 0.42 0.03 0.02*